首页 | 本学科首页   官方微博 | 高级检索  
检索        

丁酸钠抑制二甲基肼诱发小鼠大肠癌的实验研究
作者姓名:Liu CX  Zhang SZ  Zhang XW  Geng XL  Li TJ  Huang LH  Wang B
作者单位:山东大学齐鲁医院消化科,山东,济南,250012;济南市医学科学研究所,山东,济南,250013
摘    要:背景与目的:体外研究证实丁酸钠能促进多种肿瘤细胞分化,抑制细胞生长,诱导细胞凋亡。本研究给予小鼠直肠内灌注丁酸钠,旨在观察丁酸钠对二甲基肼(dimethylhydrazine,DMH)诱发的昆明种小鼠大肠癌的预防作用。方法:选择昆明种小鼠为实验对象,模型组以DMH30mg/kg,皮下注射,每周一次,连续给药11周。实验组分别以1.25×10-3mol/kg、2.5×10-3mol/kg丁酸钠溶液,直肠灌注,每天一次,连续24周。分别于给药后第12周、18周和24周分3个阶段处死小鼠。观察肿瘤的发生率,以及2.5×10-3mol/kg丁酸钠灌肠组小鼠的一般状态、体重增长、肝肾功能、以及肝、肾、肺、胰腺等病理变化。结果:实验12周各组小鼠未见肿瘤发生;18周时,模型组小鼠肿瘤发生率为58.3%(7/12),1.25×10-3mol/kg丁酸钠组肿瘤发生率为25.0%(3/12),2.5×10-3mol/kg丁酸钠组肿瘤发生率为0(0/12),各组相比差异有显著性(P<0.01);实验24周结果,模型组小鼠肿瘤发生率为95.0%(19/20),1.25×10-3mol/kg丁酸钠组肿瘤发生率45.0%(9/20),2.5×10-3mol/kg丁酸钠组肿瘤发生率为15.0%(3/20),各组间有显著性差异(P<0.01)。单纯2.5×10-3mol/kg丁酸钠灌肠组和生理盐水对照组均未发现肿瘤。单纯2.5×10-3mol/kg丁酸钠灌肠组小鼠一般状态良好,体重增长及肝、肾功能均与生理盐水灌肠组无显著性差异(P>0.05),肝脏、肾脏、胰腺等重要脏器未见病理性改变。结论:丁酸钠能够抑制DMH诱发的实验性小鼠大肠癌的发生和发展,并且无明显毒副作用发生。

关 键 词:丁酸钠/拮抗剂和抑制剂  二甲基肼/毒性  大肠肿瘤/化学诱导  大肠肿瘤/预防和控制  小鼠
文章编号:1000-467X(2005)08-0930-05
收稿时间:2004-11-09
修稿时间:2004年11月9日

Inhibitory effect of sodium butyrate on 1,2-dimethylhydrazine-induced tumorigenesis of colorectal cancer in mice
Liu CX,Zhang SZ,Zhang XW,Geng XL,Li TJ,Huang LH,Wang B.Inhibitory effect of sodium butyrate on 1,2-dimethylhydrazine-induced tumorigenesis of colorectal cancer in mice[J].Chinese Journal of Cancer,2005,24(8):930-934.
Authors:Liu Cheng-Xia  Zhang Shang-Zhong  Zhang Xiao-Wei  Geng Xiu-Lan  Li Tie-Jun  Huang Li-Hua  Wang Bing
Institution:Department of Digestive Disease, Qilu Hospital, Shandong University, Jinan, Shandong, P. R. China. bzlcx@yahoo.com.cn
Abstract:BACKGROUND & OBJECTIVE: In vitro studies proved that sodium butyrate (NaB) could stimulate cell differentiation, inhibit cell proliferation, and indu ce cell apoptosis in various tumors. This study was to evaluate the preventive e ffects of coloclysis of NaB on 1,2-dimethylhydrazine (DMH)-induced tumorigenesis of colorectal cancer in mice. METHODS: The mice of Kunming species were divided into 5 groups and received relevant treatments:DMH alone group (with subcutaneo us injection of 30 mg/kg of DMH weekly for 11 weeks), control (normal saline, NS ) group, DMH plus low dose of NaB (1.25 mol/kg, 24-week coloclysis) group, DMH p lus high dose of NaB (2.5 mol/kg, 24-week coloclysis) group, and high dose of Na B group. The mice were killed in batches at the 12th, 18th, and 24th weeks of ca rcinoma induction separately. The incidence of colorectal tumor in each group wa s observed. Meanwhile, the general condition, body weight increasing, liver and renal functions, and pathologic changes of liver, kidney, lungs, and pancreas of the mice in DMH plus high dose of NaB group were also observed. RESULTS: No tum or was observed at the 12th week in each group. At the 18th week, the tumor inci dence was significantly higher in DMH alone group and DMH plus low dose of NaB g roup than in DMH plus high dose of NaB group (58.3%, and 25.0% vs. 0, P < 0.01). At the 24th week, the tumor incidence was 95.0% in DMH alone group, 45.0% in DM H plus low dose of NaB group, and 15.0% in DMH plus high dose of NaB group; the differences among the 3 groups were significant (P=0.01, P < 0.01). No tumor was observed in control group and high dose of NaB group. There was no difference i n the general condition, body weight increasing, and liver and renal functions o f the mice between control group and high dose of NaB group (P > 0.05); no patho logic changes in liver, kidney, lungs, and pancreas were observed in the mice in high dose of NaB group. CONCLUSION: NaB could inhibit DMH-induced tumorigenesis of colorectal cancer in mice with no obvious toxicity.
Keywords:Sodium butyrate/antagonist and inhibitor  1  2-Dimethylhydra-zine (DMH) /Toxicity  Colorectal neoplasms/chemomorphosis  Colorectal neoplasms/prophylaxis and control  Mouse  
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号